Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.774 USD | +5.03% |
|
+8.56% | -33.28% |
05-17 | ABVC BioPharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-09 | Abvc Biopharma, Inc. Enters into A Definitive Agreement with Oncox Biopharma, Inc | CI |
Business Summary
Number of employees: 18
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
New Drugs and Medical Devices
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -84.28% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -84.28% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 23-06-22 | |
Leeds Chow
DFI | Director of Finance/CFO | 35 | 21-02-28 |
Eugene Jiang
CHM | Chairman | 38 | 15-06-30 |
Chief Tech/Sci/R&D Officer | 70 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yue Min Chung
BRD | Director/Board Member | 59 | 22-07-09 |
Shu Ling Chiang
BRD | Director/Board Member | 68 | - |
Eugene Jiang
CHM | Chairman | 38 | 15-06-30 |
Tsang Ming Jiang
BRD | Director/Board Member | 63 | 17-11-22 |
Norimi Sakamoto
BRD | Director/Board Member | 53 | 17-11-22 |
Yen-Hsin Chou
BRD | Director/Board Member | 43 | 17-11-22 |
Chief Tech/Sci/R&D Officer | 70 | - | |
Chang-Jen Jiang
BRD | Director/Board Member | 68 | - |
Yoshinobu Odaira
BRD | Director/Board Member | 76 | - |
Che-Wei Hsu
BRD | Director/Board Member | 43 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,878,376 | 8,003,762 ( 73.57 %) | 26,553 ( 0.2441 %) | 73.57 % |
Company contact information
![address ABVC BioPharma, Inc.(ABVC)](https://cdn.zonebourse.com/static/address/59318329.png)
Sector
![Consensus](/images/consensus_flch.gif)
1st Jan change | Capi. | |
---|---|---|
-33.28% | 8.38M | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- ABVC Stock
- Company ABVC BioPharma, Inc.